Stockreport

PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule [Yahoo! Finance]

PepGen Inc.  (PEPG) 
PDF BOSTON, November 12, 2025 BUSINESS WIRE )--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies [Read more]